NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome
Science Signaling · 23.01.2024 · 17 (820)
DOI: 10.1126/scisignal.abg8145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, erschienen am 23.01.2024. Verfasst von Jared R Coombs und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Bioscience, University of Queensland, St Lucia 4072, Australia. Hauptthemen laut MEDLINE: Hereditary Autoinflammatory Diseases, Inflammasomes. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Inflammasomes are multiprotein complexes that drive inflammation and contribute to protective immunity against pathogens and immune pathology in autoinflammatory diseases. Inflammasomes assemble when an inflammasome scaffold protein senses an activating signal and forms a signaling platform with the inflammasome adaptor protein ASC. The NLRP subfamily of NOD-like receptors (NLRs) includes inflammasome nucleators (such as NLRP3) and also NLRP12, which is genetically linked to familial autoinflammatory disorders that resemble diseases caused by gain-of-function NLRP3 mutants that generate a hyperactive NLRP3 inflammasome. We performed a screen to identify ASC inflammasome–nucleating proteins among NLRs that have the canonical pyrin-NACHT-LRR domain structure. Only NLRP3 and NLRP6 could initiate ASC polymerization to form “specks,” and NLRP12 failed to nucleate ASC polymerization. However, wild-type NLRP12 inhibited ASC inflammasome assembly induced by wild-type and gain-of-function mutant NLRP3, an effect not seen with disease-associated NLRP12 mutants. The capacity of NLRP12 to suppress NLRP3 inflammasome assembly was limited to human NLRP3 and was not observed for wild-type murine NLRP3. Furthermore, peripheral blood mononuclear cells from patients with an NLRP12 mutant–associated inflammatory disorder produced increased amounts of the inflammatory cytokine IL-1β in response to NLRP3 stimulation. Thus, our findings provide insights into NLRP12 biology and suggest that NLRP3 inhibitors in clinical trials for NLRP3-driven diseases may also be effective in treating NLRP12-associated autoinflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Molecular Bioscience, University of Queensland, St Lucia 4072, Australia.
- U1019, Institut Pasteur de Lille, University of Lille, Centre National de la Recherche Scientifique, INSERM, Centre Hospitalo-Universitaire Lille, Lille 59019, France.
- Laboratory of Cell Physiology, INSERM U1003, University of Lille, Lille 59000, France.
- School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia 4072, Australia.
ORCID-Profile: Jared R Coombs, Alina Zamoshnikova, Caroline L Holley, Madhavi P Maddugoda, Daniel Eng Thiam Teo, Camille Chauvin, Connie M Ross, Manasa Mellacheruvu, Leonhard X Heinz, Sabrina S Burgener, Stefan Emming, Mathias Chamaillard, Dave Boucher, Kate Schroder
Zitieren
APA
Coombs, J. R., Zamoshnikova, A., Holley, C. L., Maddugoda, M. P., Teo, D. E. T., Chauvin, C., Poulin, L. F., Vitak, N., Ross, C. M., Mellacheruvu, M., Coll, R. C., Heinz, L. X., Burgener, S. S., Emming, S., Chamaillard, M., Boucher, D., & Schroder, K. (2024). NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome. Science Signaling, 17(820). https://doi.org/10.1126/scisignal.abg8145
Vancouver
Coombs JR, Zamoshnikova A, Holley CL, Maddugoda MP, Teo DET, Chauvin C, et al. NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome. Science Signaling. 2024;17(820). doi:10.1126/scisignal.abg8145
BibTeX
@article{Coombs2024,
author = {Coombs, Jared R and Zamoshnikova, Alina and Holley, Caroline L and Maddugoda, Madhavi P and Teo, Daniel Eng Thiam and Chauvin, Camille and Poulin, Lionel F and Vitak, Nazarii and Ross, Connie M and Mellacheruvu, Manasa and Coll, Rebecca C and Heinz, Leonhard X and Burgener, Sabrina S and Emming, Stefan and Chamaillard, Mathias and Boucher, Dave and Schroder, Kate},
title = {NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome},
journal = {Science Signaling},
year = {2024},
volume = {17},
number = {820},
doi = {10.1126/scisignal.abg8145}
}
EUVIMED